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Atrioventricular nodal reentrant tachycardia (AVNRT) is the
most common regular supraventricular arrhythmia. It typi-
cally presents with rapid and regular palpitations of abrupt
onset in young adults, with a female preponderance. In
patients without structural heart disease, AVNRT is largely
considered to have a benign course and is rarely associated
with disabling symptoms, such as syncope.1 Herein, we
report the case of an otherwise healthy young woman with a
catastrophic presentation of AVNRT.Case report
A 26-year-old female, with no signiﬁcant medical history,
presented emergency department of the local hospital with a
2-week history of exertional dyspnea and fatigue. She denied
palpitations, chest pain, orthopnea, paroxysmal nocturnal
dyspnea, dizziness, and syncope. Review of systems and
family history were unremarkable. Her 12-lead electrocar-
diogram at presentation, shown in Figure 1, depicts a rapid
and regular supraventricular tachycardia at a rate of 180
beats/min, with a short RP interval (ie, RP interval o PR
interval). Intravenous adenosine boluses transiently inter-
rupted tachycardia, albeit with the tachyarrhythmia recurring
after a few sinus beats. Intravenous boluses of metoprolol
before adenosine injection were likewise ineffective in
preventing early recurrences. The patient was then trans-
ferred to our institution for further management of the
incessant tachycardia, where an intravenous procainamideKEYWORDS Atrioventricular nodal reentrant tachycardia; Tachycardia-
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duced lasting sinus rhythm.
Upon workup, echocardiography revealed biventricular
dysfunction with thrombus in the right ventricle. On cardiac
magnetic resonance imaging, shown in Figure 2A, biven-
tricular thrombi were identiﬁed, with a left ventricular
ejection fraction of 27% and a right ventricular ejection
fraction of 29%. Computed tomography pulmonary angiog-
raphy, displayed in Figures 2B–2D, revealed bilateral
pulmonary emboli with associated pulmonary infarction.
Coronary angiography was normal. Hematological workup
for an inherited hypercoagulable condition was negative,
including antinuclear antibodies, lupus anticoagulants, anti-
phospholipid antibodies, ﬁbrinogen, antithrombin III, pro-
tein C, protein S, factor V Leiden, homocysteine, and
prothrombin G20210A.
Standard heart failure and anticoagulation therapies were
initiated. An electrophysiology study was deferred in the
context of ventricular thrombosis. Amiodarone was admin-
istered and complicated by amiodarone-induced hypothyr-
oidism, which required thyroid replacement therapy. At 1
month of follow-up, repeat echocardiography showed reso-
lution of the intracardiac thrombi with improvement in left
ventricular function (ejection fraction 48%). An electro-
physiology study was performed under conscious sedation.
There was no evidence of an accessory pathway and no
retrograde conduction at baseline. During isoproterenol
infusion (1 mg/min), typical slow-fast AVNRT was reprodu-
cibly inducible with 2 atrial extrastimuli (Figure 3). The slow
pathway was eliminated with cryoablation by means of a
6-mm electrode tip catheter (Freezor Xtra, Medtronic Cry-
oCath LP, Montreal, Quebec, Canada). Amiodarone and
β-blockers were discontinued postprocedure. Biventricular
size and function had completely normalized at 6 months of
follow-up, prompting gradual weaning of her angiotensin-
converting enzyme inhibitor. She remains free of arrhythmia
recurrence 9 months postablation.pen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.11.012
KEY TEACHING POINTS
 Although atrioventricular nodal reentrant
tachycardia is generally considered a benign
arrhythmia in otherwise healthy individuals,
nonspeciﬁc symptoms may lead to late
presentation with untoward consequences.
 Long-standing incessant atrioventricular nodal
reentrant tachycardia can provoke tachycardia-
induced cardiomyopathy, characterized by
potentially reversible ventricular dilation and
dysfunction.
 This case report extends the spectrum of potential
major complications associated with
atrioventricular nodal reentrant tachycardia to
include severe biventricular dysfunction,
biventricular thrombosis, and pulmonary emboli
with pulmonary infarction.
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Tachycardia-induced cardiomyopathy is characterized by
reversible ventricular dilation and systolic dysfunction due
to sustained or frequent supraventricular or ventricular
arrhythmias. It has primarily been described in the context
of atrial ﬁbrillation, atrial ﬂutter, focal atrial tachyarrhyth-
mias, permanent junctional reciprocating tachycardia,
and frequent ventricular ectopy.2 The literature on theFigure 1 Presenting electrocardiogram. The electrocardiogram shows a narroassociation between AVNRT and tachycardia-induced
cardiomyopathy is limited to 1 case report of incessant
atypical (fast-slow) AVNRT mimicking permanent junc-
tional reciprocating tachycardia3 and a patient with typical
AVNRT, concomitant trifascicular block, intermittent com-
plete heart block, and a single-chamber pacemaker.4 To our
knowledge, this is the ﬁrst report of typical AVNRT
provoking tachycardia-induced cardiomyopathy in an oth-
erwise healthy individual and the ﬁrst description of
AVNRT associated with intracardiac thrombosis and pul-
monary emboli.
Although supraventricular tachycardia typically presents
with palpitations and shortness of breath, heart rates Z170
beats/min are more likely to be associated with disabling
symptoms such as syncope and dizziness.3–6 Since AVNRT
is almost always associated with palpitations, is often self-
remitting, and rarely goes unrecognized for weeks on end,
tachycardia-induced ventricular dilation and dysfunction
appear to be exceedingly rare. In our patient, there were no
atypical electrophysiological characteristics of the slow
pathway to account for the unusual clinical scenario. Rather,
the nondescript symptoms combined with an unremitting
course likely resulted in a late presentation with dire
consequences. Tachycardia-induced cardiomyopathy most
commonly presents with heart failure symptoms,2 which in
our patient developed weeks, if not months, after the onset of
tachycardia. Fortunately, as in other forms of tachycardia-
induced cardiomyopathy, cardiac function recovered upon
restoration of a stable sinus rhythm.7 In general, once
diagnosed with tachycardia-induced cardiomyopathy,w complex tachycardia at 180 beats/min with RP interval o PR interval.
Figure 2 Ventricular thrombi and pulmonary emboli. A: A cardiac magnetic resonance view in a 4-chamber orientation. Early gadolinium enhancement
imaging reveals the presence of avascular masses in the right ventricle (RV) and left ventricle (LV), suggestive of thrombi. B and C: Computed tomographic
images. In panels B and C, multiplanar reconstruction images of the left inferior lobe pulmonary artery (LPA) and interlobar right pulmonary artery (RPA) show
sharply deﬁned ﬁlling defects (asterisk), consistent with bilateral pulmonary emboli. D: A triangular opacity in the right upper lobe along the anterior chest wall
(arrow), consistent with a pulmonary infarction.
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in ventricular function such that vigilant follow-up is
required.Conclusion
Although the incidence of disabling symptoms associated
with AVNRT is generally low in patients with structurallynormal hearts, unrecognized incessant episodes can present
with tachycardia-induced cardiomyopathy. This case high-
lights the diagnostic challenges associated with nonspeciﬁc
symptoms related to AVNRT and the potential devastating
consequences. It further extends the gamut of reported major
complications associated with ANVRT to include severe
biventricular dysfunction, biventricular thrombi, and pulmo-
nary emboli with consequent pulmonary infarction.
Figure 3 Electrophysiology study. Shown are the recordings from surface electrocardiographic leads I, II, aVF, V1, and V6 and intracardiac tracings from the
high right atrium (HRA), His bundle proximal (His p) and distal (His d), coronary sinus (CS) proximal (9-10) to distal (1-2), and right ventricular apex (RVA). A
stimulation (STIM) channel is also shown. A: Two atrial extrastimuli (S2 and S3) delivered from the HRA at coupling intervals of 270 and 250 ms result in
prolongation of the A3-H3 interval, followed by sustained supraventricular tachycardia with a septal VA interval of 18 ms. B: The tachycardia (cycle length 299
ms) is entrained by ventricular pacing at 280 ms, with 1:1 ventriculoatrial conduction. Upon cessation of ventricular pacing, a V-A-H response is observed,
consistent with atrioventricular nodal reentrant tachycardia.
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